课题基金 / 基金详情

项目摘要

项目成果

Savio Chan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our Udall Center proposal continues to have a Molecular Core intended to provide scientific support to the re- search teams. The Molecular Core will provide four services to the program team. The first is to provide gene expression analysis using a combination of fluorescence activated cell sorting (FACS) and quantitative real time PCR (qPCR). Projects 1, 2, 3, and 5 make use of this approach. The second service is to provide consultation and assistance for genotyping. The projects 1, 2, 3 and 4 makes extensive use of transgenic animals that require accurate and timely genotyping. The third service is to provide assistance in the design and construction of viral vectors for gene knockdown. Both projects 2 and 3 make extensive use of this technology. The third service is to provide assistance in the design and construction of viral vectors for gene delivery. Projects 1, 2, 3 and 5 make use of this service for delivery of various expression constructs related to optogenetics, pharmacogenomics and redox reporting. Dr. C. Savio Chan, will serve as the Core Director and oversee the operation of the core. Dr. Chan has extensive experience with gene expression studies, including: single-cell, FACS-based cell-population, and tissue-level analyses. All necessary methods in the Molecular Core facility have been established previously. The Molecular Core will be administered by Dr. Chan with the assistance of Dr. Jyothisri Kondapalli. Together, they will be responsible for the day-to-day operation of the core, supervision of technical staff, purchasing supplies, etc.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GABAergic Signaling in the External Globus Pallidus
GABAergic Signaling in the External Globus Pallidus
Striatopallidal GABAergic Signaling in Mouse Models of Parkinson's Disease
Striatopallidal GABAergic Signaling in Mouse Models of Parkinson's Disease
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: